The leading corneal research presented at ASCRS offered a glimpse at the subspecialty’s most promising medical and surgical advancements.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.

A new White House report says today’s children are the sickest generation in US history when it comes to chronic disease, and it puts the blame on environmental toxins, poor nutrition and too much ...

Shared microbiomes across involved and uninvolved eyes may indicate that antibiotics are not always ideal in the treatment of chalazia.

A combined cataract and glaucoma surgery can help achieve long-term intraocular pressure reductions in patients with advanced glaucoma.

Some of the nation's top brain researchers are still facing layoffs, even after US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said no working scientists would be cut.

Asymmetry between the superior and inferior retinal hemispheres can help determine the stage of normal tension glaucoma.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.